A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians

Central African Journal of Medicine

Volumn 42, Issue 8, 1996, Pages 253-255

  Adewole, A D ^a   Ikem, R T ^a   Adigun, A Q ^a   Akintomide, A O ^a   Balogun, M O ^a   Ajayi, A A ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE;

ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; FEMALE; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NIGERIA; ORAL DRUG ADMINISTRATION; PROGNOSIS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; ENALAPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; HYPONATREMIA; LENGTH OF STAY; MALE; NIGERIA; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0029855234     PISSN: 00089176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure, N Engl J Med 1987; 316:1429-35.
2. Captopril Multicentre Research group. A placebo controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardid 1983; 2:755-63.
3. The SOL VD investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325-303-10.
4. Cohn JN. et al. A comparison of enalapril with hydraiazine - isosorbide dinitrate in the treatment of congestive heart failure. N Engl J Med 1991; 325:303:10.
5. Preffer MA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infraction: Results of survival and ventricular enlargement study. N Engl J Med 1992; 327:685-91.
6. Osotimehin B, Erasmus RT, Iyun AO, Falase AO, Ahmed Z. Plasma renin activity and plasma aldosterone concentrationin untreated Nigerians with essential hypertension. Afr J Med Med Sci 1984; 13:139-443.
7. Laragh JH. Vasoconstrictor and volume analysis for understanding and treating hypertension; the use of renin and aldosterone profiles. Am J Med 1973; 55:261-74.
8. Buhler FR, Bolli P, Wolfgang K, Erne P, Hulthen UL. Oral renin profiling to select antihypertensive baseline drugs. J Cordial 1984; 77(2A): 36-42.
9. Ajayi AA, Oyewo EA, Ladipo GOA, Akinsola A. Enalapril and hydrochlorothiaide in hypertensive Africans. Eur J Clin Pharmacol 1989; 36:229-34.
10. Goodman C, Rosendorft C, Coull A. Comparison of the antihypertensive effects of enalapril and propranolol in black South Africans. 5. Afr Med J 1985; 87:672-6.
11. Swedberg K, et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality circulation 1990; 82: 1730-6.
12. Ajayi AA, Belogun MO, Oyewo EA, Ladipo GOA. The effects of enalapril in Africans with congestive heart failure. Br J Clin Pharmacol 1989; 27: 400-3.
13. Ajayi AA, Balogun MC. Sustained beneficial effects of enalapril in Africans with congestive heart failure. Int J Cardioll 1990; 29: 55-61.
14. Ajayi AA, Oshodi OO, Akinsomide AO. The influence of captopril on intra hospital mortality and duration of hospitalization in Nigerians with congestive heart failure. Int J Cardiol 1992;36: 341-4.
15. Lee WH, Parker M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73: 257-67.
16. Goldsmith SR, Francis GS, Cowley AW, Levine TB, Cohn JN. Increased plasma argininevasopress in levels in patients with congestive heart failure. J Am Coll Cardid 1983; 1: 1385-9.
17. McMurray J. Trends in the hosptalization for chronic heart failure in Scotland. 1980 to 1990. Eur Heart J 1993; 14: 1158-62.